Compare Cognizant Technology Solutions Corp (CTSH) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cognizant Technology Solutions Corp vs Novartis AG — how do they compare? Cognizant Technology Solutions Corp trades at $58.45 (market cap $26.27B), while Novartis AG trades at $153.53 (market cap $298.18B). The key difference: Novartis AG is far larger — about 11.4× Cognizant Technology Solutions Corp's market cap, and Novartis AG pays the higher dividend (3.02%). Which is the better fit depends on your goals.
| CTSH | NVS | |
|---|---|---|
Market Cap | $26.27B | $298.18B |
Sector | Technology | Health |
52-Week High | $86.70 | $168.62 |
52-Week Low | $38.73 | $119.31 |
Enterprise Value | $27.31B | $339.50B |
Dividend Yield | 2.26% | 3.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
